Merck
Search Within
Applications
Content Type
Applied Filters:
Applications:IVD manufacturing
Content Type:Technical Article
Showing 1-20 of 20 results
Sort by Relevance
优化免疫荧光实验方案获取最优质细胞图像的技巧
免疫荧光法(IF)通过在抗体标记上荧光分子,然后使用激光器激发荧光,包括蛋白质的定位、验证翻译后修饰或活化以及与其他蛋白质的邻近和复合等操作。
荧光原位杂交(FISH)
可用的荧光原位杂交(FISH)过程、试剂和设备。
去垢剂的性质和应用
在细胞裂解、膜蛋白和脂质增溶、蛋白结晶或蛋白质免疫印迹应用中更有效地使用去垢剂。
Unannounced Audits Are Here – Are You and Your Suppliers Ready?
In May 2017, the European Union’s In Vitro Device Regulation (IVDR 2017/746) went into effect, replacing the In Vitro Diagnostic Device Directive (IVDD). The new regulation is more comprehensive than the IVDD and was introduced to reduce inconsistencies in the
10 Strategic Considerations When Outsourcing Production of In Vitro Diagnostics
The choice of whether to outsource production of an in vitro diagnostic (IVD) or invest and develop in-house capabilities is a foundational business decision. We highlight 10 important benefits of outsourcing and key considerations that should factor into the evaluation
Outsourcing for Efficiency - The Need for Increased Manufacturing Capacity
Outsourcing for Efficiency - The Need for Increased Manufacturing Capacity
Supply chain considerations when developing or manufacturing your IVD assay
The recent pandemic has highlighted that strong supply chain management should be a vital consideration for any potential clinical diagnostic CMO partner as the risk of regional and global disruptions are unlikely to disappear.
Quality & Regulatory Trends
The life sciences industry operates in one of the world’s most regulated environments. Today, we are facing increasing regulatory requirements and complexity.
Qualitative multiplex PCR assay for assessing DNA quality from FFPE tissues and other sources of damaged DNA
The assessment of DNA quality is a crucial first step in acquiring meaningful data from formalin-fixed paraffin-embedded (FFPE) tissues, and other sources of damaged DNA. Using intact genomic DNA is key for successful analysis of chromosomal aberrations (e.g. SNP analysis
Webinar: Improving Reproducibility with Biological Buffers
Experts will explore ways to improve reproducibility when using biological buffers.
Complete Solutions for IVD Chemiluminescent Immunoassay (CLIA/CLEIA) Development
Accelerate your time to market with fit-for-use products which offer the quality, consistency, and documentation necessary for every step of your IVD development and manufacturing needs.
IVD Lateral Flow Assay Development
An IVD lateral flow assay design is based on current patents, eventual manufacturing specifications, and raw material sources.
How Suppliers Impact your ISO 13485:2016 Quality Management System
Enhanced ISO 13485 requirements for IVDs must be implemented by the February 28, 2019 deadline.
Risk Mitigation in IVD Manufacturing
Assessment of critical raw material performance, supply and quality is important to minimize risk. Risk must be assessed and mitigated throughout the entire IVD commercialization process.
Fluorescent in situ Hybridization (FISH)
Available Fluorescent in situ hybridization (FISH) procedures, reagents and equipment.
Tips for Optimizing Immunofluorescence Protocols to Get the Best Image
Uses for immunofluorescence (IF)—where an antibody conjugated to a molecule that fluoresces when excited by lasers— include protein localization, confirmation of post-translational modification or activation, and proximity to/complexing with other proteins.
Outsourcing Security - The need to ensure consistency and continuity of supply in IVD Kit Manufacturing
Outsourcing Security - The need to ensure consistency and continuity of supply in IVD Kit Manufacturing
Case Study: Elypta Needed Contract Manufacturing for a Novel Metabolism-Based Liquid Biopsy
Elypta partnered with us to produce the first standardized extraction kit for GAG quantification in bodily fluids for research use. Our contract manufacturing services move Elypta one step closer to meeting growing customer demands for this novel research assay as
Sensitivity Lateral Flow Diagnostic Assays
Steven J. Oldenburg, Ph.D. provides an overview of lateral flow diagnostic assays and discusses the use of ultra-bright reporter particles based on the unique optical properties of gold nanoshells that significantly increase the sensitivity of lateral flow immunoassays.
Vetting a Contract Manufacturing Partner for Your Clinical Diagnostics Kit
While the commercialization pathway for IVD devices is complicated, a knowledgeable contract manufacturing partner can save significant time, money, and aggravation by providing design, quality, and regulatory assistance.